Yixin Ally Wang

Yixin Wang practices at Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania.

Yixin Wang's NPI, 1790313526, was assigned on March 28, 2020. Yixin Wang holds Pennsylvania license MD484525.

Yixin Wang's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-2737.

Yixin Wang's primary practice is Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania. Yixin Wang is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Yixin Wang to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yixin Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Yixin Wang's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Yixin Wang is licensed in Pennsylvania.

CMS data shows 180 Medicare services from Yixin Wang across 7 procedure codes in 2024, for 108 Medicare patients. Medicare paid $11,978 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Yixin Wang in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high cholesterol, and 57% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Yixin Wang's median patient age at 46, with 63% women.

In 2024, Yixin Wang wrote 266 Medicare Part D claims for 108 patients. 92% of them were for generic drugs. CMS names the drug for 200 of them, across 7 drugs with 11 or more claims each, at $5,624 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.

Yixin Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Yixin Wang as offering telehealth. CMS counts 384 procedures of removal of skin lesions by Yixin Wang, more than 84% of the clinicians it reports for that procedure.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Yixin Wang, published from 2010 to 2025. 2022 was the busiest year, with 15. The most frequent topics are Biomarkers, Tumor, Endothelial Cells and Neoplastic Cells, Circulating. Yixin Wang has published most often in Carbohydr Polym. Yixin Wang's most frequent co-authors are David B. Agus, MD, Eric Arthur Anderson, MD and Bernard R. Chaitman, MD.

CMS Open Payments shows 5 general payments to Yixin Wang from 4 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 82% of the total. Incyte Corporation paid the most, $177.